Retina Global is a US based 501(c)(3) nonprofit that is focused on finding sustainable solutions to the ever-increasing issues with retinal diseases in underserved areas around the world.
Food and Drug Administration (FDA) has approved Allergan's Ozurdex (dexamethasone 0.7 mg, a sustained-release biodegradable intravitreal implant), for the treatment of diabetic macular edema (DME).
